Longevity Health (XAGE) Income Statement (2021 - 2026)
Income Statement report data from Mar 31, 2021 to Mar 31, 2026 for Longevity Health (XAGE).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | ||||||||||||||||||||
Total Revenue | 390K (-17.02%) | 470K (+9.30%) | 430K (-14.00%) | 500K (-1.96%) | 510K (+2450.00%) | 20K (0.00%) | 20K (+100.00%) | 10K | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit | 240K (-11.11%) | 270K (+8.00%) | 250K (-16.67%) | 300K (+11.11%) | 270K (+1250.00%) | 20K (0.00%) | 20K (+100.00%) | 10K | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses | ||||||||||||||||||||
Research And Development | 60K (-40.00%) | 100K (-56.52%) | 230K (-11.54%) | 260K (+30.00%) | 200K (+5.26%) | 190K (-42.42%) | 330K (+230.00%) | 100K (-76.74%) | 430K | -660.00K | 1.59M (+93.90%) | 820K (+10.81%) | 740K (-54.60%) | 1.63M (+185.96%) | 570K | - | - | - | - | - |
Selling General And Administrative | 270K | -650.00K | 360K (-74.83%) | 1.43M (+410.71%) | 280K (+366.67%) | 60K (-50.00%) | 120K (+1100.00%) | 10K | - | - | - | - | - | - | - | - | - | 90K | - | - |
Operating Expenses | 1.57M (-38.67%) | 2.56M (+47.98%) | 1.73M (-19.16%) | 2.14M (+20.22%) | 1.78M (+74.51%) | 1.02M (-29.17%) | 1.44M (+20.00%) | 1.20M (-13.04%) | 1.38M (+318.18%) | 330K (-88.42%) | 2.85M (+91.28%) | 1.49M (+17.32%) | 1.27M (-72.75%) | 4.66M (+448.24%) | 850K | - | - | 90K | - | - |
Depreciation And Amortization | 20K (0.00%) | 20K (0.00%) | 20K (0.00%) | 20K (0.00%) | 20K (0.00%) | 20K (0.00%) | 20K (0.00%) | 20K (0.00%) | 20K (0.00%) | 20K (0.00%) | 20K (-33.33%) | 30K (+50.00%) | 20K (-71.43%) | 70K (+250.00%) | 20K | - | - | - | - | - |
Operating Income | ||||||||||||||||||||
Operating Income | -1.33M (-41.41%) | -2.27M (+54.42%) | -1.47M (-20.97%) | -1.86M (+23.18%) | -1.51M (+49.50%) | -1.01M (-28.87%) | -1.42M (+19.33%) | -1.19M (-13.77%) | -1.38M (+318.18%) | -330.00K (-88.42%) | -2.85M (+91.28%) | -1.49M (+17.32%) | -1.27M (-66.84%) | -3.83M (+350.59%) | -850.00K (+193.10%) | -290.00K (-46.30%) | -540.00K (+500.00%) | -90.00K (+800.00%) | -10.00K | - |
Ebit | -1.33M (-41.41%) | -2.27M (+54.42%) | -1.47M (-20.97%) | -1.86M (+23.18%) | -1.51M (+49.50%) | -1.01M (-28.87%) | -1.42M (+19.33%) | -1.19M (-13.77%) | -1.38M (+318.18%) | -330.00K (-88.42%) | -2.85M (+91.28%) | -1.49M (+17.32%) | -1.27M (-66.84%) | -3.83M (+350.59%) | -850.00K (+193.10%) | -290.00K (-46.30%) | -540.00K (+500.00%) | -90.00K (+800.00%) | -10.00K | - |
EBITDA | -1.31M (-41.78%) | -2.25M (+55.17%) | -1.45M (-21.20%) | -1.84M (+24.32%) | -1.48M (+49.49%) | -990.00K (-29.29%) | -1.40M (+19.66%) | -1.17M (-13.97%) | -1.36M (+338.71%) | -310.00K (-89.05%) | -2.83M (+93.84%) | -1.46M (+16.80%) | -1.25M (-68.59%) | -3.98M (+379.52%) | -830.00K (+937.50%) | -80.00K (-84.91%) | -530.00K | 40K | -10.00K | - |
Other Income / Expenses | ||||||||||||||||||||
Interest Expense | - | 10K (0.00%) | 10K | - | - | 10K (0.00%) | 10K | - | 10K (-50.00%) | 20K (0.00%) | 20K | - | - | - | - | - | - | - | - | - |
Net Interest Income | - | -10.00K (0.00%) | -10.00K | - | - | -10.00K (0.00%) | -10.00K | - | -10.00K (-50.00%) | -20.00K (0.00%) | -20.00K | - | - | - | - | - | - | - | - | - |
Other Non Operating Income | -100.00K | 240K (+500.00%) | 40K | -30.00K | - | -5.75M | 10K (-50.00%) | 20K | -2.17M (-78.85%) | -10.26M | 10K | - | -550.00K (-84.46%) | -3.54M (-32.18%) | -5.22M | - | - | - | - | - |
Net Income | ||||||||||||||||||||
Income Before Tax | -1.43M (-30.24%) | -2.05M (+43.36%) | -1.43M (-24.34%) | -1.89M (+25.17%) | -1.51M (+49.50%) | -1.01M (-64.93%) | -2.88M (-12.73%) | -3.30M (-7.04%) | -3.55M (+35400.00%) | -10.00K (-99.89%) | -9.06M (+70.62%) | -5.31M (+190.16%) | -1.83M (-23.11%) | -2.38M (-60.79%) | -6.07M (+7487.50%) | -80.00K (-84.91%) | -530.00K | 40K | -10.00K | - |
Income Tax Expense | - | 40K | - | - | - | -100.00K | - | - | - | - | - | - | - | -270.00K | - | 270K | - | - | - | - |
Net Income From Continuing Operations | -1.43M (-31.25%) | -2.08M (+45.45%) | -1.43M (-24.34%) | -1.89M (+25.17%) | -1.51M (+65.93%) | -910.00K (-68.40%) | -2.88M (-12.73%) | -3.30M (+0.92%) | -3.27M | 3.16M | -11.46M (+115.82%) | -5.31M (+190.16%) | -1.83M (-13.27%) | -2.11M (-65.24%) | -6.07M (+1634.29%) | -350.00K (-33.96%) | -530.00K | 40K | -10.00K | - |
Net Income | -1.43M (-31.25%) | -2.08M (+45.45%) | -1.43M (-24.34%) | -1.89M (+25.17%) | -1.51M (+65.93%) | -910.00K (-68.40%) | -2.88M (-12.73%) | -3.30M (+0.92%) | -3.27M | 3.16M | -11.46M (+115.82%) | -5.31M (+190.16%) | -1.83M (-13.27%) | -2.11M (-65.24%) | -6.07M (+1634.29%) | -350.00K (-33.96%) | -530.00K | 40K | -10.00K | - |